D.E. Shaw & Co’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

D.E. Shaw & Co’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,992	Closed	-$472K	–	4655
2023 Q2	$472K	Hold	45,992	–	–	﹤0.01%	3447
2023 Q1	$465K	Hold	45,992	–	–	﹤0.01%	3583
2022 Q4	$460K	Hold	45,992	–	–	﹤0.01%	3897
2022 Q3	$446K	Hold	45,992	–	–	﹤0.01%	4111
2022 Q2	$446K	Hold	45,992	–	–	﹤0.01%	4161
2022 Q1	$448K	Buy	45,992 +2,300	+5%	+$22.2K	﹤0.01%	4438
2021 Q4	$429K	Buy	43,692 +23,916	+121%	+$234K	﹤0.01%	4490
2021 Q3	$194K	Buy	+19,776	New	+$195K	﹤0.01%	4576

D.E. Shaw & Co's DALS Position: Q3 2023 in Review

D.E. Shaw & Co sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 45,992 shares — an estimated $472K sold.

D.E. Shaw & Co first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $472K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

D.E. Shaw & Co reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
D.E. Shaw & Co sold 45,992 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $472K.
D.E. Shaw & Co first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
D.E. Shaw & Co's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $472K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.